{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:08:31Z","timestamp":1792109311575,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002193","name":"Lupus Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jacc.2020.05.045","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T16:25:22Z","timestamp":1594657522000},"page":"292-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":207,"title":["Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA\/Ro-Positive Mothers"],"prefix":"10.1016","volume":"76","author":[{"given":"Peter","family":"Izmirly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Copel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin K.L.","family":"Phoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina F.","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Robins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Zahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.05.045_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.1919","article-title":"Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature","volume":"26","author":"Jaeggi","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jacc.2020.05.045_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zeron","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jacc.2020.05.045_bib3","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/mpd.2003.233","article-title":"Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies","volume":"142","author":"Cimaz","year":"2003","journal-title":"J\u00a0Ped"},{"key":"10.1016\/j.jacc.2020.05.045_bib5","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.20554","article-title":"Outcome of pregnancies in patients with anti-SSA\/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group","volume":"50","author":"Costedoat-Chalumeau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.05.045_bib7","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.05.045_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/1529-0131(200102)44:2<487::AID-ANR70>3.0.CO;2-D","article-title":"The rate of recurrence of isolated congenital heart block: a population-based study","volume":"44","author":"Julkunen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-2002-23555","article-title":"Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and\/or anti-La antibodies","volume":"19","author":"Gladman","year":"2002","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jacc.2020.05.045_bib10","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/annrheumdis-2011-200207","article-title":"Development of heart block in children of SSA\/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern","volume":"71","author":"Ambrosi","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.05.045_bib15","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.05.045_bib16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/rheumatology\/ker515","article-title":"Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus","volume":"51","author":"Llanos","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jacc.2020.05.045_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.11430","article-title":"Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage\/fibroblast crosstalk in the pathologic cascade leading to congenital heart block","volume":"50","author":"Clancy","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jaut.2015.09.003","article-title":"Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7\/8 ligation to forestall tissue injury in anti-Ro60 associated heart block","volume":"67","author":"Clancy","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jacc.2020.05.045_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4049\/jimmunol.1202849","article-title":"Ro60 Requires Y3 RNA for cell surface exposure and inflammation associated with cardiac manifestations of neonatal lupus","volume":"191","author":"Reed","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jacc.2020.05.045_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4049\/jimmunol.1800357","article-title":"Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block","volume":"202","author":"Clancy","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jacc.2020.05.045_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000989","article-title":"Type I IFN system activation in newborns exposed to Ro\/SSA and La\/SSB autoantibodies in utero","volume":"6","author":"Hedlund","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.jacc.2020.05.045_bib22","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines","volume":"186","author":"Kuznik","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jacc.2020.05.045_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/mol.113.089821","article-title":"Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in\u00a0vivo","volume":"85","author":"Lamphier","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jacc.2020.05.045_bib24","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.09.020","article-title":"Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents","volume":"208","author":"Tunks","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2020.05.045_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12026-016-8888-5","article-title":"Obstetric and perinatal outcome in anti-Ro\/SSA-positive pregnant women: a prospective cohort study","volume":"65","author":"Martinez-Sanchez","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.jacc.2020.05.045_bib27","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/rheumatology\/kex191","article-title":"Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study","volume":"56","author":"Barsalou","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jacc.2020.05.045_bib28","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1136\/annrheumdis-2018-213718","article-title":"Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus","volume":"77","author":"Barsalou","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jacc.2020.05.045_bib30","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.05.045_bib31","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/annrheumdis-2012-202322","article-title":"Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)","volume":"72","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/FTD.0000000000000614","article-title":"Development and validation of a fast ultra-high performance liquid chromatography-fluorescent method for the quantification of hydroxychloroquine and its metabolites in patients with lupus","volume":"41","author":"Noe","year":"2019","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jacc.2020.05.045_bib33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/sim.1653","article-title":"On the estimation of the binomial probability in multistage clinical trials","volume":"23","author":"Jung","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2020.05.045_bib34","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/sim.3123","article-title":"Proper inference from Simon's two-stage designs","volume":"27","author":"Koyama","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2020.05.045_bib35","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.jacc.2018.07.076","article-title":"Home monitoring for fetal heart rhythm during anti-ro pregnancies","volume":"72","author":"Cuneo","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.05.045_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature","volume":"4","author":"Costedoat-Chalumeau","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jacc.2020.05.045_bib38","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/acr.23808","article-title":"Risk of ocular anomalies in children exposed in utero to antimalarials: a systematic literature review","volume":"71","author":"Gaffar","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jacc.2020.05.045_bib39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2165\/00002018-200629100-00003","article-title":"Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future","volume":"29","author":"Vroom","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacc.2020.05.045_bib40","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jacc.2020.05.045_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/annrheumdis-2017-211641","article-title":"Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study","volume":"77","author":"Skorpen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib42","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Gotestam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jacc.2020.05.045_bib45","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.62.10.1010","article-title":"Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block","volume":"62","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib46","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib47","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib48","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2020.05.045_bib49","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2020.05.045_bib51","first-page":"857","article-title":"No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine","volume":"35","author":"Friedman","year":"2017","journal-title":"Clin Exp Rheumatol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720354024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720354024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:34:01Z","timestamp":1760016841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720354024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0735109720354024"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.05.045","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA\/Ro-Positive Mothers","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}